Hospital@Home: Person-centered Digital Transformation for Integrated Home Care
€14.2M
01 Jan 2026 → 31 Dec 2030
22
organizations
Objective
The Hospital@Home (H@H) project unites leading academic hospitals and industry in Europe to provide hospital-level care to patients right to their own homes. Designed around five major clinical areas – cardiovascular disease, pulmonary disease, minor stroke/TIA, migraine, and cluster headache – the H@H project is designed to improve clinical and patient-reported outcomes, enhance patient experience and reduce hospital burden to enable sustainable health systems across Europe. H@H’s powerful, interdisciplinary consortium consists of five leading European university hospitals, MedTech and Pharma partners, patient organizations, and health economics experts. Supported by a robust digital infrastructure, the project integrates wearable monitoring, AI-driven predictive analytics, patient-reported outcomes (PROMs/PREMs) and digital decision support into real-world care pathways. Patient and healthcare professional engagement, ethics, equity and system-level sustainability are structurally woven into every phase of the project’s three-phased methodology of Mapping, Testing, and Implementing. H@H directly addresses the goals of IHI Call 9 Topic 3 by overcoming real-world barriers to digital care integration while firmly placing people’s needs and preferences at the center of the care transformation. The trustworthy AI-supported H@H system will generate new evidence on patient-centered models by integrating PROMs, PREMs, and real-world data. H@H delivers scalable digital platforms and AI tools to improve efficiency, reduce costs, and enable sustainable business models. H@H will deliver actionable blueprints for Europe’s healthcare future - boosting patient outcomes while easing system burdens through high-quality, accessible home care.
Click “Summarize” to get an AI-powered analysis of this project.
Call Topics
Consortium(22 organizations)
| Organization | Country | Type | SME | Website |
|---|---|---|---|---|
MEDIZINISCHE UNIVERSITAET WIEN | AT | HES | — | |
EUROPEAN MIGRAINE AND HEADACHE ALLIANCE | BE | OTH | — | — |
Hict | BE | PRC | SME | — |
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT CSEM | CH | REC | — | |
Skyvor Medical AG | CH | PRC | — | — |
AARHUS UNIVERSITETSHOSPITAL AUH | DK | REC | — | |
EMENTO | DK | PRC | — | — |
NOVARTIS HEALTHCARE AS | DK | PRC | — | — |
TRIFORK PUBLIC AS Trifork Public A/S | DK | PRC | — | — |
PREDICTBY RESEARCH AND CONSULTING S.L. PREDICTBY | ES | PRC | SME | — |
GLOBAL HEART HUB COMPANY LIMITED BY GUARANTEE | IE | OTH | — | — |
ACADEMISCH ZIEKENHUIS LEIDEN Leiden University Medical Center | NL | HES | — | |
ANCORA HEALTH BV | NL | PRC | SME | — |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM ERASMUS MC | NL | HES | — | |
FWDFASTER AI Research BV | NL | PRC | SME | — |
Novartis Pharma B.V. | NL | PRC | — | — |
PHILIPS ELECTRONICS NEDERLAND BV | NL | PRC | — | |
SALVIA BIOELECTRONICS BV Salvia BioElectronics | NL | PRC | SME | — |
TECHNISCHE UNIVERSITEIT EINDHOVEN TU/e | NL | HES | — | |
Novartis Sverige Aktiebolag | SE | PRC | — | — |
REGION STOCKHOLM RS | SE | PUB | — | |
UMAN SENSE AB UMANSENSE AB | SE | PRC | SME | — |